Enterobiome Inc.

9 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Oct 2036

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 21, 2027
The maintenance fee for Use of Akkermansia muciniphila for treating inflammatory conditions (US 10,537,597) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 10,537,597	Use of Akkermansia muciniphila for treating inflammatory conditions In force Term ends Oct 5, 2036 · From the USPTO record	In force	Term ends Oct 5, 2036	From the USPTO record
US 10,960,032	Use of Akkermansia Muciniphila for Treating Inflammatory Conditions In force Ends no later than Oct 5, 2036 · Low confidence	In force	Ends no later than Oct 5, 2036	Low confidence
US 11,439,670	Akkermansia muciniphila EB-AMDK27 strain and use thereof In force Term ends Jul 2, 2040 · From the USPTO record	In force	Term ends Jul 2, 2040	From the USPTO record
US 12,514,882	Novel Faecalibacterium Prausnitzii Strain EB-FPDK11 and Use Thereof In force Term ends Nov 7, 2040 · High confidence	In force	Term ends Nov 7, 2040	High confidence
US 11,377,633	Medium supplement for high-yield industrial culture of fastidious anaerobes and medium composition containing the same In force Term ends Dec 28, 2040 · From the USPTO record	In force	Term ends Dec 28, 2040	From the USPTO record
US 12,351,794	Medium supplement for high-yield industrial culture of fastidious anaerobes and medium composition containing the same In force Term ends Jan 20, 2042 · From the USPTO record	In force	Term ends Jan 20, 2042	From the USPTO record
US 12,319,907	The Composition of Culture Media for Faecalibacterium Prausnitzii In force Term ends Feb 7, 2042 · High confidence	In force	Term ends Feb 7, 2042	High confidence
US 12,622,934	Pharmaceutical Composition for Preventing or Treating Atopic Disease Containing Faecalibacterium Prausnitzii Strain In force Ends no later than Aug 17, 2042 · Medium confidence	In force	Ends no later than Aug 17, 2042	Medium confidence
US 12,636,319	Pharmaceutical Composition for Preventing or Treating Atopic Disease Containing Akkermansia Muciniphila Strain In force Ends no later than Dec 10, 2043 · Medium confidence	In force	Ends no later than Dec 10, 2043	Medium confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 1 abandoned · 1 no status recorded

List them